-+ 0.00%
-+ 0.00%
-+ 0.00%

Keros director Jean Jacques Bienaime acquires $10,580 common shares

PUBT·05/19/2026 20:16:25
Listen to the news
Keros director Jean Jacques Bienaime acquires $10,580 common shares
  • Keros Therapeutics director Jean Jacques Bienaime bought 1,000 common shares at a weighted average price of $10.58.
  • Direct holdings rose to 9,450 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001221590-26-000009), on May 19, 2026, and is solely responsible for the information contained therein.